Prospective Applications of MicroRNAs in Oral Cancer

Overview

Journal Oncol Lett

Specialty Oncology

Date 2019 Oct 4

PMID 31579085

Citations 22

Authors

Chuan Fang

Yadong Li

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are non-coding RNA molecules that are generally encoded by endogenous genes and exert suppressive effects on post-transcriptional regulation of their target genes by translation repression or degradation of mRNA. This subsequently mediates activation or blocking of downstream signaling pathways associated with oral malignancies. Aberrant levels of certain miRNAs have been identified in cell experiments, clinical carcinomatous specimens, saliva, serum or plasma samples of patients with oral malignancies. miRNAs are associated with multiple aspects of oral cancer, including tumor growth, cellular proliferation, apoptosis, migration, invasion, metastasis, glycometabolism, radiosensitivity and chemosensitivity. miRNAs have the potential to be used in clinical applications as minimally invasive or non-invasive tools for early diagnosis and prognosis by the detection of serum, plasma and saliva levels, and may provide a new ancillary or additional reference index of traditional pathological grading and clinical staging. Furthermore, miRNAs may be used as prognostic biomarkers or targets for novel therapies for oral cancer.

Citing Articles

The oncogenic potential of salivary microRNA-93 and microRNA-412-3p in oral lichen planus: a case-control study.

ELHefny M, Korien I, Rashwan W, Shaker O BDJ Open. 2024; 10(1):98.

PMID: 39715775 PMC: 11666714. DOI: 10.1038/s41405-024-00278-5.

miRNA in Machine-Learning-Based Diagnostics of Oral Cancer.

Li X, Kouznetsova V, Tsigelny I Biomedicines. 2024; 12(10).

PMID: 39457716 PMC: 11504892. DOI: 10.3390/biomedicines12102404.

Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis.

Arfin S, Kumar D, Lomagno A, Mauri P, Silvestre D Cancers (Basel). 2023; 15(17).

PMID: 37686696 PMC: 10563081. DOI: 10.3390/cancers15174420.

Gingival Tissue MiRNA Expression Profiling and an Analysis of Periodontitis-Specific Circulating MiRNAs.

Buragaite-Staponkiene B, Rovas A, Puriene A, Snipaitiene K, Punceviciene E, Rimkevicius A Int J Mol Sci. 2023; 24(15).

PMID: 37569358 PMC: 10418511. DOI: 10.3390/ijms241511983.

Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.

Dey S, Biswas B, Manoj Appadan A, Shah J, Pal J, Basu S Cancers (Basel). 2023; 15(15).

PMID: 37568568 PMC: 10417002. DOI: 10.3390/cancers15153752.

References

Yang C, Hung P, Wang P, Liu C, Chu T, Cheng H . miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med. 2011; 40(5):397-404. DOI: 10.1111/j.1600-0714.2010.01003.x. View

Lim H, Kim C, Kim J, Yu S, Go D, Lee S . Suppression of Oral Carcinoma Oncogenic Activity by microRNA-203 Down-regulation of . Anticancer Res. 2017; 37(10):5425-5433. DOI: 10.21873/anticanres.11970. View

Sun L, Liang J, Wang Q, Li Z, Du Y, Xu X . MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion. Cell Prolif. 2016; 49(5):628-35. PMC: 6495205. DOI: 10.1111/cpr.12287. View

Zheng G, Li N, Jia X, Peng C, Luo L, Deng Y . MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer. J Mol Med (Berl). 2016; 94(10):1129-1141. DOI: 10.1007/s00109-016-1417-0. View

Lu Y, Chang J, Huang Y, Huang C, Chen W, Lee L . Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer. Clin Biochem. 2014; 48(3):115-21. DOI: 10.1016/j.clinbiochem.2014.11.020. View

Lin J, Lin Y, Fan L, Kuang W, Zheng L, Wu J . miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer. Biochem Biophys Res Commun. 2016; 473(2):382-7. DOI: 10.1016/j.bbrc.2016.02.105. View

Wang Z, Yan J, Zou T, Gao H . MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc. Oncol Lett. 2018; 16(2):2243-2250. PMC: 6036472. DOI: 10.3892/ol.2018.8967. View

Arnaoutakis D, Bishop J, Westra W, Califano J . Recurrence patterns and management of oral cavity premalignant lesions. Oral Oncol. 2013; 49(8):814-7. DOI: 10.1016/j.oraloncology.2013.04.008. View

Lin Z, Sun L, Chen W, Liu B, Wang Y, Fan S . miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1. Cancer Sci. 2014; 105(10):1288-98. PMC: 4462345. DOI: 10.1111/cas.12499. View

10.

Wang J, Wang W, Li J, Wu L, Song M, Meng Q . miR182 activates the Ras-MEK-ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1. Onco Targets Ther. 2017; 10:667-679. PMC: 5308578. DOI: 10.2147/OTT.S121864. View

11.

Park N, Zhou H, Elashoff D, Henson B, Kastratovic D, Abemayor E . Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009; 15(17):5473-7. PMC: 2752355. DOI: 10.1158/1078-0432.CCR-09-0736. View

12.

Nagai H, Hasegawa S, Uchida F, Terabe T, Kanno N, Kato K . MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression. Int J Oncol. 2018; 52(3):841-850. DOI: 10.3892/ijo.2018.4260. View

13.

Anastasiadou E, Faggioni A, Trivedi P, Slack F . The Nefarious Nexus of Noncoding RNAs in Cancer. Int J Mol Sci. 2018; 19(7). PMC: 6073630. DOI: 10.3390/ijms19072072. View

14.

El-Hefnawy T, Raja S, Kelly L, Bigbee W, Kirkwood J, Luketich J . Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem. 2004; 50(3):564-73. DOI: 10.1373/clinchem.2003.028506. View

15.

Xu P, Li Y, Yang S, Yang H, Tang J, Li M . Micro-ribonucleic acid 143 (MiR-143) inhibits oral squamous cell carcinoma (OSCC) cell migration and invasion by downregulation of phospho-c-Met through targeting CD44 v3. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120(1):43-51. DOI: 10.1016/j.oooo.2015.02.486. View

16.

Lu Y, Chen Y, Wang H, Tsai C, Chen W, Huang Y . Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila). 2012; 5(4):665-74. DOI: 10.1158/1940-6207.CAPR-11-0358. View

17.

Yeh L, Liu C, Wong Y, Chang C, Lin S, Chang K . miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo. Oncotarget. 2015; 6(8):6062-75. PMC: 4467422. DOI: 10.18632/oncotarget.3340. View

18.

Liu B, Chen W, Cao G, Dong Z, Xu J, Luo T . MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway. Arch Oral Biol. 2017; 83:92-96. DOI: 10.1016/j.archoralbio.2017.07.009. View

19.

Zhang B, Li Y, Hou D, Shi Q, Yang S, Li Q . MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor. Cell Physiol Biochem. 2017; 42(5):2105-2117. DOI: 10.1159/000479913. View

20.

Zhao J, Chi J, Gao M, Zhi J, Li Y, Zheng X . Loss of PTEN Expression Is Associated With High MicroRNA 24 Level and Poor Prognosis in Patients With Tongue Squamous Cell Carcinoma. J Oral Maxillofac Surg. 2017; 75(7):1449.e1-1449.e8. DOI: 10.1016/j.joms.2017.03.025. View